BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 251,200 shares, a growth of 175.1% from the October 31st total of 91,300 shares. Based on an average trading volume of 367,200 shares, the short-interest ratio is currently 0.7 days.
BlackRock Capital Allocation Term Trust Trading Up 0.7 %
Shares of BCAT opened at $16.30 on Friday. BlackRock Capital Allocation Term Trust has a 52-week low of $14.68 and a 52-week high of $17.18. The firm has a 50-day moving average price of $16.22 and a 200 day moving average price of $16.32.
BlackRock Capital Allocation Term Trust Increases Dividend
The company also recently announced a monthly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were issued a dividend of $0.2885 per share. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date was Friday, November 15th. This represents a $3.46 annualized dividend and a yield of 21.24%.
Insider Transactions at BlackRock Capital Allocation Term Trust
Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Penserra Capital Management LLC acquired a new position in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter worth $15,901,000. Prevail Innovative Wealth Advisors LLC acquired a new stake in BlackRock Capital Allocation Term Trust during the 2nd quarter worth about $1,452,000. Almitas Capital LLC purchased a new stake in BlackRock Capital Allocation Term Trust during the second quarter valued at about $728,000. Quarry LP boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 68.4% in the second quarter. Quarry LP now owns 69,034 shares of the company’s stock worth $1,133,000 after buying an additional 28,045 shares during the period. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of BlackRock Capital Allocation Term Trust by 4.3% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock worth $2,186,000 after acquiring an additional 5,438 shares in the last quarter. 36.12% of the stock is owned by institutional investors.
BlackRock Capital Allocation Term Trust Company Profile
–
Further Reading
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- What is a support level?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Manufacturing Stocks Investing
- 3 Penny Stocks Ready to Break Out in 2025
- Using the MarketBeat Dividend Yield Calculator
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.